Healthcare After NASH Hopes Are Dashed, Intercept Pharma Agrees to $794M Buyout By / September 26, 2023
Healthcare Reata Pharma Drug Wins First FDA Nod in Extremely-Uncommon Neuromuscular Dysfunction By / March 1, 2023
